Global

‡ In these countries please contact our distributor

RENASYS TOUCH

Overview

Introducing RENASYS TOUCH

The RENASYS TOUCH Device is the innovative, simple and effective Negative Pressure Wound Therapy (NPWT) choice. It is designed to provide individualized NPWT for highly complex wounds. This facilitates effective therapy while supporting individualized patient care in acute care institutions.

  • Intuitive touchscreen puts a friendly face on NPWT
  • Adjustable volume, compression rates and therapy modes enable adaptive, individualized care that optimizes the patient experience
  • Built in quick reference guide and troubleshooting assistance to provide device operation guidance at the touch of a button

The RENASYS TOUCH device leverages the latest in component technology and advanced software processing to create a user interface that is easy to navigate while delivering accurate, consistent performance.

Please click on the links below to download:

RENASYS TOUCH Sales Brochure

RENASYS TOUCH 510k Letter


User-friendly

  • Intuitive
  • Set and start therapy from Home screen
  • One press to Settings, Log and Help menus

 

Advanced therapy selection

  • Range of therapy set points (-25 to -200mmHg) for a variety of wound types
  • Intermittent therapy set points (0 to -200mmHg) and cycle times may be adjusted for precise control

 

Leak assessment

  • Flow Meter aids in locating and resolving alarms
  • Leak check during draw down promotes confident dressing  application

 

Daily, detailed pump activity logs

  • Pump usage data provides confidence in adherence to therapy
  • Visibility to utilization helps identify pump activity interruptions

 

Product specifications

Please click on the link to download the RENASYS TOUCH spec sheet.

 

Some Precautions

The use of negative pressure presents a risk of tissue ingrowth into the foam/gauze. Tissue ingrowth may be reduced by lowering therapy pressure, using a wound contact layer or by increasing the frequency of dressing changes.

 

Some Warnings

Carefully monitor patients for signs of bleeding, which may lead to interruption in therapy and hemodynamic instability. If such symptoms are observed, immediately discontinue therapy, take appropriate measures to control bleeding, and contact treating clinician.

For detailed product information, including indications for use, contraindications effects, precautions and warnings, please consult each product’s Instructions for Use (IFU) prior to use.